Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis

Cell Metabolism

Volumn 12, Issue 2, 2010, Pages 187-193

  Lo Sasso, Giuseppe ^a   Murzilli, Stefania ^a   Salvatore, Lorena ^a   D'Errico, Ilenia ^a   Petruzzelli, Michele ^a   Conca, Paola ^c   Jiang, Zhao Yan ^d   Calabresi, Laura ^c   Parini, Paolo ^d   Moschetta, Antonio ^a,b  

^a Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABCG5 PROTEIN; ABCG8 PROTEIN; ACAT2 ENZYME; CHOLESTEROL; ENZYME; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIVER X RECEPTOR ALPHA; MESSENGER RNA; PRE BETA HIGH DENSITY LIPOPROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE CHOLESTEROL TRANSPORT; TRANSGENIC MOUSE; UPREGULATION;

EID: 78651346813     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2010.07.002     Document Type: Article

References (33)

1. Brunham, L. R., Kruit, J. K., Iqbal, J., Fievet, C, Timmins, J. M., Pape, T. D., Coburn, B. A., Bissada, N., Staels, B., Groen, A. K., et al. (2006a). Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116, 1052-1062.
2. Brunham, L. R., Kruit, J. K., Pape, T. D., Parks, J. S., Kuipers, F., and Hayden, M. R. (2006b). Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels. Circ. Res. 99, 672-674. (Pubitemid 44498301)
3. Duval, C, Touche, V., Tailleux, A., Fruchart, J. C., Fievet, C, Clavey, V., Staels, B., and Lestavel, S. (2006). Niemann-Pick C1 like 1 gene expression is downregulated by LXR activators in the intestine. Biochem. Biophys. Res. Commun. 340, 1259-1263. (Pubitemid 43083413)
4. Galman, C, Arvidsson, I., Angelin, B., and Rudling, M. (2003). Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. J. Lipid Res. 44, 859-866.
5. Greenberg, M. E., Smith, J. D., and Sehayek, E. (2009). Moderately decreased cholesterol absorption rates are associated with a large atheroprotective effect. Arterioscler. Thromb. Vasc. Biol. 29, 1745-1750.
6. Grefhorst, A., Elzinga, B. M., Voshol, P. J., Plosch, T., Kok, T., Bloks, V. W., van der Sluijs, F. H., Havekes, L. M., Romijn, J. A., Verkade, H. J., and Kuipers, F. (2002). Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277, 34182-34190.
7. Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., and Mangelsdorf, D. J. (1996). An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383, 728-731. (Pubitemid 26360651)
8. Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., et al. (2002). Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 99, 7604-7609. (Pubitemid 34568738)
9. Klucken, J., Buchler, C, Orso, E., Kaminski, W. E., Porsch-Ozcurumez, M., Liebisch, G., Kapinsky, M., Diederich, W., Drobnik, W., Dean, M., et al. (2000). ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc. Natl. Acad. Sci. USA 97, 817-822. (Pubitemid 30070393)
10. Kratzer, A., Buchebner, M., Pfeifer, T., Becker, T. M., Uray, G., Miyazaki, M., Miyazaki-Anzai, S., Ebner, B., Chandak, P. G., Kadam, R. S., et al. (2009). Synthetic LXR agonist attenuates plaque formation in apoE-/-mice without inducing liver steatosis and hypertriglyceridemia. J. Lipid Res. 50, 312-326.
11. Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C., Kast, H. R., Mangelsdorf, D. J., and Tontonoz, P. (2001). LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA 98, 507-512. (Pubitemid 32105072)
12. Linsel-Nitschke, P., and Tall, A. R. (2005). HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat. Rev. Drug Discov. 4, 193-205. (Pubitemid 40372554)
13. Madison, B. B., Dunbar, L., Qiao, X. T., Braunstein, K., Braunstein, E., and Gumucio, D. L. (2002). Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277, 33275-33283. (Pubitemid 34984848)
14. Naik, S. U., Wang, X., Da Silva, J. S., Jaye, M., Macphee, C. H., Reilly, M. P., Billheimer, J. T., Rothblat, G. H., and Rader, D. J. (2006). Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113, 90-97. (Pubitemid 43958493)
15. Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., and Fogelman, A. M. (2000). Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J. Lipid Res. 41, 1495-1508.
16. Oram, J. F., and Vaughan, A. M. (2000). ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr. Opin. Lipidol. 11, 253-260. (Pubitemid 30336022)
17. Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J. M., Hammer, R. E., and Mangelsdorf, D. J. (1998). Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93, 693-704. (Pubitemid 28257577)
18. Peng, D., Hiipakka, R. A., Dai, Q., Guo, J., Reardon, C. A., Getz, G. S., and Liao, S. (2008). Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J. Pharmacol. Exp. Ther. 327, 332-342.
19. Rader, D. J. (2002). High-density lipoproteins and atherosclerosis. Am. J. Cardiol. 90, 62i-70i. (Pubitemid 35284912)
20. Rader, D. J. (2003). Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 92, 42J-49J.
21. Repa, J. J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J. M., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., and Mangelsdorf, D. J. (2000a). Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14, 2819-2830.
22. Repa, J. J., Turley, S. D., Lobaccaro, J. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., and Mangelsdorf, D. J. (2000b). Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524-1529.
23. Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H., and Mangelsdorf, D. J. (2002). Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 277, 18793-18800. (Pubitemid 34952438)
24. Repa, J. J., Turley, S. D., Quan, G., and Dietschy, J. M. (2005). Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J. Lipid Res. 46, 779-789. (Pubitemid 43073288)
25. Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000). Role of LXRs in control of lipogenesis. Genes Dev. 14, 2831-2838.
26. Terasaka, N., Hiroshima, A., Koieyama, T., Ubukata, N., Morikawa, Y., Nakai, D., and Inaba, T. (2003). T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett. 536, 6-11. (Pubitemid 36206397)
27. van der Velde, A. I., Vrins, C. L., van den Oever, K., Kunne, C., Oude Elferink, R. P., Kuipers, F., and Groen, A. K. (2007). Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology 133, 967-975. (Pubitemid 47374133)
28. Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., and Tontonoz, P. (2000). Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 97, 12097-12102.
29. Wang, N., Lan, D., Chen, W., Matsuura, F., and Tall, A. R. (2004). ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to highdensity lipoproteins. Proc. Natl. Acad. Sci. USA 101, 9774-9779. (Pubitemid 38869312)
30. Willner, E. L., Tow, B., Buhman, K. K., Wilson, M., Sanan, D. A., Rudel, L. L., and Farese, R. V., Jr. (2003). Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA 100, 1262-1267. (Pubitemid 36183990)
31. Willy, P. J., and Mangelsdorf, D. J. (1997). Unique requirements for retinoiddependent transcriptional activation by the orphan receptor LXR. Genes Dev. 11, 289-298. (Pubitemid 27079907)
32. Yasuda, T., Grillot, D., Billheimer, J. T., Briand, F., Delerive, P., Huet, S., and Rader, D. J. (2010). Tissue-specific liverx receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler. Thromb. Vasc. Biol. 30, 781-786.
33. Zilversmit, D. B. (1979). Atherogenesis: a postprandial phenomenon. Circulation 60, 473-485. (Pubitemid 9254048)